普米克令舒雾化吸入干预毛细支气管炎后哮喘发病率的效果探讨

目的　观察布地奈德 (budesonide,普米克令舒 )吸入疗法对减少毛细支气管炎后哮喘发病率的作用。方法　分组观察毛细支气管炎的患儿临床缓解后吸入和不吸入普米克令舒雾化液后 2年哮喘的发病率。结果　吸入组患儿发病率 14 .0 % ,对照组发病率为 33.3% ,二者有显著性差异 (P <0 .0 5 )。结论　在毛细支气管炎缓解后吸入普米克令舒可明显降低哮喘的发病率。

Study on the intervention effect of inhaling budesonide on incidence of asthma after bronchiolitis

OBJECTIVE To investigate the effect of inhaling Pulmicort Respules on decreasing the incidence of asthma after bronchiolitis. METHOD Compare the incidence of asthma in children with bronchiolitis had or had not been inhaled Pulmicort Respules after clinical remission.RESULTS The incidence of inhaling group was 14.0% and the incidence of control group was 33.3%, there was remarkable difference between the two group(P<0.05).CONCLUSION Inhaling Pulmicort Respules can obviously reduce the incidence of asthma after bronchiolitis remission.